68 Spam-Free Article(s) Found
Sort:
Relevance
Like
Date
Filter:
7d
All
DeepLinks
Article Searches
Abbott (ABT) to Reduce Childhood Malnutrition With New Pact https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550 Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
Here's Why You Should Retain Walgreens Boots (WBA) For Now https://www.zacks.com/stock/news/2237551/here-s-why-you-should-retain-walgreens-boots-wba-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2237551 Mar 07, 2024 - Investors are optimistic about Walgreens Boots (WBA), led by its strategic partnerships and long-term growth model.
Medtronic's (MDT) MiniMed 780G System Study Data Favorable https://www.zacks.com/stock/news/2238698/medtronic-s-mdt-minimed-780g-system-study-data-favorable?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2238698 Mar 11, 2024 - Medtronic's (MDT) data from a recent study indicate that the MiniMed 780G system exceeds international targets for TIR and even brings patients closer to euglycemia.
Integra LifeSciences (IART) Introduces MicroMatrix Flex https://www.zacks.com/stock/news/2239482/integra-lifesciences-iart-introduces-micromatrix-flex?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2239482 Mar 12, 2024 - Integra LifeSciences' (IART) MicroMatrix Flex has a flexible tip that delivers a flowable version of the Urinary Bladder Matrix (UBM) technology.
Here's Why You Should Retain Globus Medical (GMED) Stock Now https://www.zacks.com/stock/news/2240217/here-s-why-you-should-retain-globus-medical-gmed-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2240217 Mar 13, 2024 - Investors are optimistic about Globus Medical (GMED), led by growth in the U.S. spine business and progress in the recently merged NuVasive business.
Charles River (CRL) Extends Gene Therapy Offering With New Pact https://www.zacks.com/stock/news/2241549/charles-river-crl-extends-gene-therapy-offering-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2241549 Mar 15, 2024 - Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
Labcorp (LH) Presents New Research on Precision Diagnostics https://www.zacks.com/stock/news/2242254/labcorp-lh-presents-new-research-on-precision-diagnostics?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2242254 Mar 18, 2024 - Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100 https://www.zacks.com/stock/news/2243024/inspira-technologies-iinn-strives-to-get-amar-nod-for-art100?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2243024 Mar 19, 2024 - The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
Here's Why You Should Retain Tandem Diabetes (TNDM) Now https://www.zacks.com/stock/news/2242630/here-s-why-you-should-retain-tandem-diabetes-tndm-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2242630 Mar 19, 2024 - Product innovations and strategic progress bode well for Tandem Diabetes (TNDM).
Here's Why Investors Should Retain Abbott (ABT) Stock Now https://www.zacks.com/stock/news/2243034/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243034 Mar 19, 2024 - Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre.

Pages: 1234567

<Page 2>